- ►annals.org SR Salpeter, TM Ormiston, EE Salpeter - Annals of internal medicine, 2002 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To assess the effect of cardioselective ß-blockers on ... Cited by 148 - Related articles - BL Direct - All 8 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2002 - ti.ubc.ca Objective: To assess the effect of cardioselective -blockers on respiratory
function of patients with reactive airway disease. Data Sources: Comprehensive
searches of the EMBASE, MED- LINE, and CINAHL databases from 1966 to May ... Related articles - View as HTML - All 8 versions
SR Salpeter, TM Ormiston, EE Salpeter, PJ … - Respiratory medicine, 2003 - Elsevier Beta-blocker therapy has a mortality benefit in patients with hypertension,
heart failure and coronary artery disease, as well as during the perioperative
period. These drugs have traditionally been considered contraindicated in ... Cited by 66 - Related articles - All 8 versions
S Salpeter, T Ormiston, E Salpeter - Cochrane Database Systemic Review, 2005 - ti.ubc.ca Page 1. Cardioselective beta-blockers for chronic obstructive pulmonary
disease (Review) Salpeter S, Ormiston T, Salpeter E This ... Cited by 104 - Related articles - View as HTML - BL Direct - All 9 versions
E Kotlyar, AM Keogh, PS Macdonald, RH … - Journal of Heart and Lung Transplantation, 2002 - Elsevier In patients with COPD, mean forced expiratory volume in one second (FEV 1 ) was
62% ± 13% predicted, reversibility was 4% ± 4% with bronchodilators, and FEV 1
/FVC was 62% ± 8%. Mean PEFR was 325 ± 115 liter/min before the dose and ... Cited by 61 - Related articles - All 7 versions
- ►onlinejacc.org J Chen, MJ Radford, Y Wang, TA Marciniak, … - Journal of the American College of Cardiology, 2001 - Elsevier Of 54,962 patients without contraindications to beta-blockers, patients with
COPD or asthma (20%) were significantly less likely to be prescribed
beta-blockers at discharge after AMI. After adjusting for demographic and ... Cited by 98 - Related articles - BL Direct - All 11 versions
A Çamsarı, S Arıkan, C Avan, D Kaya, H … - Heart and Vessels, 2003 - Springer Abstract The coexistence of coronary artery disease (CAD) and chronic
obstructive pulmonary disease (COPD) is frequent because of common etiological
factors. β- Blockers remain underutilized in patients with CAD who also ... Cited by 22 - Related articles - BL Direct - All 3 versions
RA Dart, S Gollub, J Lazar, C Nair, D … - Chest, 2003 - chestjournal.chestpubs.org We present a two-part review of the English-language literature pertaining to
drug therapy for systemic high BP in patients with pulmonary diseases. Part I
examines the literature pertaining to the use of antihypertensive drugs in ... Cited by 38 - Related articles - BL Direct - All 10 versions
- ►oxfordjournals.org [PDF] D Poldermans, E Boersma, JJ Bax, IR Thomson … - European Heart Journal, 2001 - Eur Soc Cardiology Page 1. European Heart Journal (2001) 22, 1353–1358 doi:10.1053/euhj.2000.2555,
available online at http://www.idealibrary.com on ... Cited by 129 - Related articles - BL Direct - All 3 versions
K Albouaini, M Andron, A Alahmar, M Egred, 2007 - pubmedcentral.nih.gov The mortality and incidence of chronic obstructive pulmonary disease (COPD) and
coronary heart disease increase with age. Despite the clear evidence of beta
blockers (BBs) effectiveness, there is a general reluctance to use them in ... Cited by 3 - Related articles - BL Direct - All 6 versions
